Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neuroblastoma 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Myeloid, Acute 1 Leukemia, Monocytic, Acute 1 Leukemia, Megakaryoblastic, Acute 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, Erythroblastic, Acute 1 Leukemia, Eosinophilic, Acute 1 Leukemia, Basophilic, Acute 1 Congenital Abnormalities 1 Blast Crisis 1 Anemia, Refractory, with Excess of Blasts 1

Interventions

Cyclophosphamide 56 Etoposide 40 Filgrastim 37 Carboplatin 34 Vincristine 30 Doxorubicin 30 Melphalan 27 Topotecan 25 Isotretinoin 24 Peripheral Blood Stem Cell Transplantation 23 Granulocyte Colony-Stimulating Factor 22 Cisplatin 21 Irinotecan 20 sargramostim 18 Temozolomide 17 humanized 3F8 anti-GD2 monoclonal antibody 15 Radiotherapy 15 3-Iodobenzylguanidine 13 Granulocyte-Macrophage Colony-Stimulating Factor 11 Busulfan 11 dinutuximab 10 Interleukin-2 9 aldesleukin 8 Thiotepa 8 Ifosfamide 8 etoposide phosphate 7 Mesna 7 Vorinostat 6 Stem Cell Transplantation 6 Polymerase Chain Reaction 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Neuroblastoma × XK 469 × Clear all

NCT00028522 2013-12-16

R(+)XK469 in Treating Patients With Advanced Neuroblastoma

National Cancer Institute (NCI)

Phase 1 Completed

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡